nodes	percent_of_prediction	percent_of_DWPC	metapath
Permethrin—CYP2B6—Thiotepa—urinary bladder cancer	0.436	0.524	CbGbCtD
Permethrin—CYP3A4—Thiotepa—urinary bladder cancer	0.134	0.161	CbGbCtD
Permethrin—CYP2B6—Cisplatin—urinary bladder cancer	0.12	0.145	CbGbCtD
Permethrin—CYP2B6—Doxorubicin—urinary bladder cancer	0.0807	0.0969	CbGbCtD
Permethrin—CYP3A4—Etoposide—urinary bladder cancer	0.0363	0.0436	CbGbCtD
Permethrin—CYP3A4—Doxorubicin—urinary bladder cancer	0.0248	0.0298	CbGbCtD
Permethrin—Stinging—Mitomycin—urinary bladder cancer	0.00883	0.0565	CcSEcCtD
Permethrin—Tingling sensation—Fluorouracil—urinary bladder cancer	0.0037	0.0237	CcSEcCtD
Permethrin—Stinging—Fluorouracil—urinary bladder cancer	0.00367	0.0235	CcSEcCtD
Permethrin—Numbness—Fluorouracil—urinary bladder cancer	0.00359	0.0229	CcSEcCtD
Permethrin—Sensory loss—Fluorouracil—urinary bladder cancer	0.00344	0.022	CcSEcCtD
Permethrin—Tingling sensation—Etoposide—urinary bladder cancer	0.00322	0.0206	CcSEcCtD
Permethrin—Erythema—Mitomycin—urinary bladder cancer	0.00313	0.02	CcSEcCtD
Permethrin—Numbness—Etoposide—urinary bladder cancer	0.00312	0.0199	CcSEcCtD
Permethrin—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.00303	0.0194	CcSEcCtD
Permethrin—Sensory loss—Etoposide—urinary bladder cancer	0.00298	0.0191	CcSEcCtD
Permethrin—Pain—Carboplatin—urinary bladder cancer	0.00294	0.0188	CcSEcCtD
Permethrin—Body temperature increased—Valrubicin—urinary bladder cancer	0.00293	0.0187	CcSEcCtD
Permethrin—Abdominal pain—Valrubicin—urinary bladder cancer	0.00293	0.0187	CcSEcCtD
Permethrin—Body temperature increased—Carboplatin—urinary bladder cancer	0.00271	0.0173	CcSEcCtD
Permethrin—Pruritus—Valrubicin—urinary bladder cancer	0.00262	0.0168	CcSEcCtD
Permethrin—Diarrhoea—Valrubicin—urinary bladder cancer	0.00254	0.0162	CcSEcCtD
Permethrin—Dizziness—Valrubicin—urinary bladder cancer	0.00245	0.0157	CcSEcCtD
Permethrin—Vomiting—Valrubicin—urinary bladder cancer	0.00236	0.0151	CcSEcCtD
Permethrin—Rash—Valrubicin—urinary bladder cancer	0.00234	0.0149	CcSEcCtD
Permethrin—Dermatitis—Valrubicin—urinary bladder cancer	0.00233	0.0149	CcSEcCtD
Permethrin—Headache—Valrubicin—urinary bladder cancer	0.00232	0.0148	CcSEcCtD
Permethrin—Nausea—Valrubicin—urinary bladder cancer	0.0022	0.0141	CcSEcCtD
Permethrin—Pain—Mitomycin—urinary bladder cancer	0.00218	0.014	CcSEcCtD
Permethrin—Body temperature increased—Mitomycin—urinary bladder cancer	0.00202	0.0129	CcSEcCtD
Permethrin—Stinging—Epirubicin—urinary bladder cancer	0.00179	0.0114	CcSEcCtD
Permethrin—Diarrhoea—Mitomycin—urinary bladder cancer	0.00175	0.0112	CcSEcCtD
Permethrin—Dizziness—Mitomycin—urinary bladder cancer	0.00169	0.0108	CcSEcCtD
Permethrin—Stinging—Doxorubicin—urinary bladder cancer	0.00166	0.0106	CcSEcCtD
Permethrin—Vomiting—Mitomycin—urinary bladder cancer	0.00162	0.0104	CcSEcCtD
Permethrin—Rash—Mitomycin—urinary bladder cancer	0.00161	0.0103	CcSEcCtD
Permethrin—Dermatitis—Mitomycin—urinary bladder cancer	0.00161	0.0103	CcSEcCtD
Permethrin—Headache—Mitomycin—urinary bladder cancer	0.0016	0.0102	CcSEcCtD
Permethrin—Erythema—Thiotepa—urinary bladder cancer	0.00157	0.0101	CcSEcCtD
Permethrin—Nausea—Mitomycin—urinary bladder cancer	0.00152	0.00969	CcSEcCtD
Permethrin—Hypoaesthesia—Fluorouracil—urinary bladder cancer	0.00149	0.0095	CcSEcCtD
Permethrin—Erythema—Gemcitabine—urinary bladder cancer	0.00132	0.00846	CcSEcCtD
Permethrin—Erythema—Fluorouracil—urinary bladder cancer	0.0013	0.00832	CcSEcCtD
Permethrin—Hypoaesthesia—Etoposide—urinary bladder cancer	0.00129	0.00825	CcSEcCtD
Permethrin—Erythema—Cisplatin—urinary bladder cancer	0.00123	0.00788	CcSEcCtD
Permethrin—Paraesthesia—Thiotepa—urinary bladder cancer	0.00115	0.00737	CcSEcCtD
Permethrin—Pain—Thiotepa—urinary bladder cancer	0.0011	0.00702	CcSEcCtD
Permethrin—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00105	0.00671	CcSEcCtD
Permethrin—Abdominal pain—Thiotepa—urinary bladder cancer	0.00102	0.00649	CcSEcCtD
Permethrin—Body temperature increased—Thiotepa—urinary bladder cancer	0.00102	0.00649	CcSEcCtD
Permethrin—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00097	0.0062	CcSEcCtD
Permethrin—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000954	0.00609	CcSEcCtD
Permethrin—Pain—Gemcitabine—urinary bladder cancer	0.000924	0.0059	CcSEcCtD
Permethrin—Pruritus—Thiotepa—urinary bladder cancer	0.000908	0.00581	CcSEcCtD
Permethrin—Pain—Fluorouracil—urinary bladder cancer	0.000908	0.0058	CcSEcCtD
Permethrin—Paraesthesia—Cisplatin—urinary bladder cancer	0.000904	0.00578	CcSEcCtD
Permethrin—CYP2B6—Fatty acids—CYP4B1—urinary bladder cancer	0.000896	0.0811	CbGpPWpGaD
Permethrin—Diarrhoea—Thiotepa—urinary bladder cancer	0.000879	0.00561	CcSEcCtD
Permethrin—Pain—Cisplatin—urinary bladder cancer	0.000861	0.0055	CcSEcCtD
Permethrin—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000854	0.00546	CcSEcCtD
Permethrin—Dizziness—Thiotepa—urinary bladder cancer	0.000849	0.00543	CcSEcCtD
Permethrin—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00084	0.00537	CcSEcCtD
Permethrin—Paraesthesia—Etoposide—urinary bladder cancer	0.000828	0.00529	CcSEcCtD
Permethrin—Vomiting—Thiotepa—urinary bladder cancer	0.000816	0.00522	CcSEcCtD
Permethrin—Rash—Thiotepa—urinary bladder cancer	0.00081	0.00517	CcSEcCtD
Permethrin—Dermatitis—Thiotepa—urinary bladder cancer	0.000809	0.00517	CcSEcCtD
Permethrin—Headache—Thiotepa—urinary bladder cancer	0.000804	0.00514	CcSEcCtD
Permethrin—Body temperature increased—Cisplatin—urinary bladder cancer	0.000796	0.00509	CcSEcCtD
Permethrin—Pain—Etoposide—urinary bladder cancer	0.000789	0.00504	CcSEcCtD
Permethrin—Pruritus—Gemcitabine—urinary bladder cancer	0.000764	0.00488	CcSEcCtD
Permethrin—Nausea—Thiotepa—urinary bladder cancer	0.000763	0.00487	CcSEcCtD
Permethrin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000754	0.00482	CcSEcCtD
Permethrin—Pruritus—Fluorouracil—urinary bladder cancer	0.000751	0.0048	CcSEcCtD
Permethrin—CYP3A4—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.000748	0.0677	CbGpPWpGaD
Permethrin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000739	0.00472	CcSEcCtD
Permethrin—Body temperature increased—Etoposide—urinary bladder cancer	0.000729	0.00466	CcSEcCtD
Permethrin—Abdominal pain—Etoposide—urinary bladder cancer	0.000729	0.00466	CcSEcCtD
Permethrin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000727	0.00464	CcSEcCtD
Permethrin—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000724	0.00463	CcSEcCtD
Permethrin—Dizziness—Fluorouracil—urinary bladder cancer	0.000702	0.00449	CcSEcCtD
Permethrin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000689	0.0044	CcSEcCtD
Permethrin—Vomiting—Gemcitabine—urinary bladder cancer	0.000687	0.00439	CcSEcCtD
Permethrin—Rash—Gemcitabine—urinary bladder cancer	0.000681	0.00435	CcSEcCtD
Permethrin—Dermatitis—Gemcitabine—urinary bladder cancer	0.00068	0.00435	CcSEcCtD
Permethrin—Erythema—Methotrexate—urinary bladder cancer	0.000677	0.00433	CcSEcCtD
Permethrin—Headache—Gemcitabine—urinary bladder cancer	0.000677	0.00432	CcSEcCtD
Permethrin—Vomiting—Fluorouracil—urinary bladder cancer	0.000675	0.00432	CcSEcCtD
Permethrin—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00067	0.00428	CcSEcCtD
Permethrin—Rash—Fluorouracil—urinary bladder cancer	0.00067	0.00428	CcSEcCtD
Permethrin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000669	0.00428	CcSEcCtD
Permethrin—Headache—Fluorouracil—urinary bladder cancer	0.000665	0.00425	CcSEcCtD
Permethrin—Pruritus—Etoposide—urinary bladder cancer	0.000653	0.00417	CcSEcCtD
Permethrin—Nausea—Gemcitabine—urinary bladder cancer	0.000642	0.0041	CcSEcCtD
Permethrin—Vomiting—Cisplatin—urinary bladder cancer	0.00064	0.00409	CcSEcCtD
Permethrin—Rash—Cisplatin—urinary bladder cancer	0.000635	0.00406	CcSEcCtD
Permethrin—Dermatitis—Cisplatin—urinary bladder cancer	0.000634	0.00405	CcSEcCtD
Permethrin—Erythema—Epirubicin—urinary bladder cancer	0.000634	0.00405	CcSEcCtD
Permethrin—Diarrhoea—Etoposide—urinary bladder cancer	0.000631	0.00403	CcSEcCtD
Permethrin—Nausea—Fluorouracil—urinary bladder cancer	0.000631	0.00403	CcSEcCtD
Permethrin—CYP2B6—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.000617	0.0558	CbGpPWpGaD
Permethrin—Dizziness—Etoposide—urinary bladder cancer	0.00061	0.0039	CcSEcCtD
Permethrin—Nausea—Cisplatin—urinary bladder cancer	0.000598	0.00382	CcSEcCtD
Permethrin—Vomiting—Etoposide—urinary bladder cancer	0.000586	0.00375	CcSEcCtD
Permethrin—Erythema—Doxorubicin—urinary bladder cancer	0.000586	0.00375	CcSEcCtD
Permethrin—Rash—Etoposide—urinary bladder cancer	0.000582	0.00372	CcSEcCtD
Permethrin—Dermatitis—Etoposide—urinary bladder cancer	0.000581	0.00371	CcSEcCtD
Permethrin—Headache—Etoposide—urinary bladder cancer	0.000578	0.00369	CcSEcCtD
Permethrin—SCN1A—L1CAM interactions—CNTN2—urinary bladder cancer	0.000566	0.0512	CbGpPWpGaD
Permethrin—Nausea—Etoposide—urinary bladder cancer	0.000548	0.0035	CcSEcCtD
Permethrin—Paraesthesia—Methotrexate—urinary bladder cancer	0.000496	0.00317	CcSEcCtD
Permethrin—Pain—Methotrexate—urinary bladder cancer	0.000472	0.00302	CcSEcCtD
Permethrin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.000466	0.0422	CbGpPWpGaD
Permethrin—Paraesthesia—Epirubicin—urinary bladder cancer	0.000464	0.00297	CcSEcCtD
Permethrin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000452	0.00289	CcSEcCtD
Permethrin—Pain—Epirubicin—urinary bladder cancer	0.000442	0.00283	CcSEcCtD
Permethrin—Body temperature increased—Methotrexate—urinary bladder cancer	0.000437	0.00279	CcSEcCtD
Permethrin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000437	0.00279	CcSEcCtD
Permethrin—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00043	0.00275	CcSEcCtD
Permethrin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000423	0.0027	CcSEcCtD
Permethrin—Pain—Doxorubicin—urinary bladder cancer	0.000409	0.00261	CcSEcCtD
Permethrin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000409	0.00261	CcSEcCtD
Permethrin—Body temperature increased—Epirubicin—urinary bladder cancer	0.000409	0.00261	CcSEcCtD
Permethrin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000391	0.0025	CcSEcCtD
Permethrin—Pruritus—Methotrexate—urinary bladder cancer	0.000391	0.0025	CcSEcCtD
Permethrin—CYP3A4—Estrogen metabolism—UGT2B7—urinary bladder cancer	0.000391	0.0354	CbGpPWpGaD
Permethrin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000378	0.00242	CcSEcCtD
Permethrin—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000378	0.00242	CcSEcCtD
Permethrin—Diarrhoea—Methotrexate—urinary bladder cancer	0.000378	0.00242	CcSEcCtD
Permethrin—Pruritus—Epirubicin—urinary bladder cancer	0.000366	0.00234	CcSEcCtD
Permethrin—Dizziness—Methotrexate—urinary bladder cancer	0.000365	0.00233	CcSEcCtD
Permethrin—Diarrhoea—Epirubicin—urinary bladder cancer	0.000354	0.00226	CcSEcCtD
Permethrin—Vomiting—Methotrexate—urinary bladder cancer	0.000351	0.00224	CcSEcCtD
Permethrin—Rash—Methotrexate—urinary bladder cancer	0.000348	0.00223	CcSEcCtD
Permethrin—Dermatitis—Methotrexate—urinary bladder cancer	0.000348	0.00222	CcSEcCtD
Permethrin—Headache—Methotrexate—urinary bladder cancer	0.000346	0.00221	CcSEcCtD
Permethrin—CYP3A4—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.000345	0.0313	CbGpPWpGaD
Permethrin—Dizziness—Epirubicin—urinary bladder cancer	0.000342	0.00218	CcSEcCtD
Permethrin—Pruritus—Doxorubicin—urinary bladder cancer	0.000338	0.00216	CcSEcCtD
Permethrin—Vomiting—Epirubicin—urinary bladder cancer	0.000329	0.0021	CcSEcCtD
Permethrin—Nausea—Methotrexate—urinary bladder cancer	0.000328	0.0021	CcSEcCtD
Permethrin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000327	0.00209	CcSEcCtD
Permethrin—Rash—Epirubicin—urinary bladder cancer	0.000326	0.00208	CcSEcCtD
Permethrin—Dermatitis—Epirubicin—urinary bladder cancer	0.000326	0.00208	CcSEcCtD
Permethrin—Headache—Epirubicin—urinary bladder cancer	0.000324	0.00207	CcSEcCtD
Permethrin—Dizziness—Doxorubicin—urinary bladder cancer	0.000316	0.00202	CcSEcCtD
Permethrin—Nausea—Epirubicin—urinary bladder cancer	0.000307	0.00196	CcSEcCtD
Permethrin—Vomiting—Doxorubicin—urinary bladder cancer	0.000304	0.00194	CcSEcCtD
Permethrin—Rash—Doxorubicin—urinary bladder cancer	0.000302	0.00193	CcSEcCtD
Permethrin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000301	0.00193	CcSEcCtD
Permethrin—Headache—Doxorubicin—urinary bladder cancer	0.0003	0.00192	CcSEcCtD
Permethrin—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000296	0.0268	CbGpPWpGaD
Permethrin—CYP2B6—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000292	0.0264	CbGpPWpGaD
Permethrin—Nausea—Doxorubicin—urinary bladder cancer	0.000284	0.00182	CcSEcCtD
Permethrin—CYP3A4—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.00028	0.0254	CbGpPWpGaD
Permethrin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—urinary bladder cancer	0.000246	0.0223	CbGpPWpGaD
Permethrin—CYP2B6—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00024	0.0217	CbGpPWpGaD
Permethrin—CYP2B6—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000239	0.0216	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—CNTN2—urinary bladder cancer	0.000214	0.0194	CbGpPWpGaD
Permethrin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.000212	0.0192	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—GSTZ1—urinary bladder cancer	0.000163	0.0148	CbGpPWpGaD
Permethrin—CYP2B6—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000161	0.0146	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—GSTO2—urinary bladder cancer	0.000155	0.014	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—NAT1—urinary bladder cancer	0.000155	0.014	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—CNTN2—urinary bladder cancer	0.000153	0.0138	CbGpPWpGaD
Permethrin—CYP2B6—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000152	0.0138	CbGpPWpGaD
Permethrin—CYP3A4—Estrogen metabolism—NQO1—urinary bladder cancer	0.000151	0.0137	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—UGT2B7—urinary bladder cancer	0.000141	0.0128	CbGpPWpGaD
Permethrin—CYP2B6—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000139	0.0126	CbGpPWpGaD
Permethrin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000134	0.0122	CbGpPWpGaD
Permethrin—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000133	0.012	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—CYP4B1—urinary bladder cancer	0.000127	0.0115	CbGpPWpGaD
Permethrin—CYP2B6—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000126	0.0114	CbGpPWpGaD
Permethrin—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000116	0.0105	CbGpPWpGaD
Permethrin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.00011	0.00993	CbGpPWpGaD
Permethrin—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000109	0.00986	CbGpPWpGaD
Permethrin—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000108	0.00982	CbGpPWpGaD
Permethrin—SCN1A—L1CAM interactions—SRC—urinary bladder cancer	9.65e-05	0.00874	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—NAT2—urinary bladder cancer	8.47e-05	0.00767	CbGpPWpGaD
Permethrin—SCN1A—L1CAM interactions—EGFR—urinary bladder cancer	8.46e-05	0.00766	CbGpPWpGaD
Permethrin—CYP2B6—Metapathway biotransformation—NAT2—urinary bladder cancer	8.35e-05	0.00756	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	7.41e-05	0.00671	CbGpPWpGaD
Permethrin—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	7.31e-05	0.00662	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	7.02e-05	0.00636	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	7.02e-05	0.00636	CbGpPWpGaD
Permethrin—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	6.93e-05	0.00627	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—HPGDS—urinary bladder cancer	6.77e-05	0.00613	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—GSTT1—urinary bladder cancer	6.57e-05	0.00595	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	6.42e-05	0.00582	CbGpPWpGaD
Permethrin—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	6.33e-05	0.00574	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	5.78e-05	0.00524	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—NCOR1—urinary bladder cancer	5.71e-05	0.00517	CbGpPWpGaD
Permethrin—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	5.7e-05	0.00516	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—RHOA—urinary bladder cancer	4.98e-05	0.00451	CbGpPWpGaD
Permethrin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	4.98e-05	0.00451	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—ERBB2—urinary bladder cancer	4.61e-05	0.00418	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—GSTP1—urinary bladder cancer	4.55e-05	0.00412	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—CDK4—urinary bladder cancer	4.5e-05	0.00408	CbGpPWpGaD
Permethrin—CYP2B6—Metapathway biotransformation—GSTP1—urinary bladder cancer	4.49e-05	0.00406	CbGpPWpGaD
Permethrin—CYP2B6—Biological oxidations—GSTM1—urinary bladder cancer	4.18e-05	0.00379	CbGpPWpGaD
Permethrin—CYP2B6—Metapathway biotransformation—GSTM1—urinary bladder cancer	4.12e-05	0.00374	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—PPARG—urinary bladder cancer	4.09e-05	0.0037	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—MMP9—urinary bladder cancer	3.96e-05	0.00358	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—CREBBP—urinary bladder cancer	3.93e-05	0.00356	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	3.85e-05	0.00348	CbGpPWpGaD
Permethrin—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	3.8e-05	0.00344	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—SRC—urinary bladder cancer	3.65e-05	0.0033	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—RHOA—urinary bladder cancer	3.56e-05	0.00322	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—ERBB2—urinary bladder cancer	3.29e-05	0.00298	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—EGFR—urinary bladder cancer	3.2e-05	0.00289	CbGpPWpGaD
Permethrin—Fenoprofen—PTGS2—urinary bladder cancer	3.1e-05	1	CrCbGaD
Permethrin—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	3.08e-05	0.00279	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—KRAS—urinary bladder cancer	3.02e-05	0.00273	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	2.98e-05	0.0027	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—MMP9—urinary bladder cancer	2.82e-05	0.00256	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—GSTZ1—urinary bladder cancer	2.79e-05	0.00252	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—EP300—urinary bladder cancer	2.68e-05	0.00242	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—GSTO2—urinary bladder cancer	2.64e-05	0.00239	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—NAT1—urinary bladder cancer	2.64e-05	0.00239	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—SRC—urinary bladder cancer	2.6e-05	0.00236	CbGpPWpGaD
Permethrin—SCN1A—Axon guidance—HRAS—urinary bladder cancer	2.57e-05	0.00232	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—UGT2B7—urinary bladder cancer	2.42e-05	0.00219	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—EGFR—urinary bladder cancer	2.28e-05	0.00207	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—CYP4B1—urinary bladder cancer	2.18e-05	0.00197	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—TNF—urinary bladder cancer	2.17e-05	0.00197	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—KRAS—urinary bladder cancer	2.16e-05	0.00195	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	2.07e-05	0.00187	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—SLC19A1—urinary bladder cancer	2.06e-05	0.00186	CbGpPWpGaD
Permethrin—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	2.04e-05	0.00185	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—PRSS3—urinary bladder cancer	2e-05	0.00181	CbGpPWpGaD
Permethrin—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	1.9e-05	0.00172	CbGpPWpGaD
Permethrin—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	1.87e-05	0.0017	CbGpPWpGaD
Permethrin—SCN1A—Developmental Biology—HRAS—urinary bladder cancer	1.83e-05	0.00166	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—TYMP—urinary bladder cancer	1.6e-05	0.00145	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—NAT2—urinary bladder cancer	1.45e-05	0.00131	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	1.27e-05	0.00115	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—RRM2—urinary bladder cancer	1.25e-05	0.00113	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	1.2e-05	0.00109	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—NAT1—urinary bladder cancer	1.2e-05	0.00109	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	1.16e-05	0.00105	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—ENO2—urinary bladder cancer	1.16e-05	0.00105	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	1.12e-05	0.00102	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.1e-05	0.000995	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	9.89e-06	0.000896	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	9.34e-06	0.000846	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—NQO1—urinary bladder cancer	9.33e-06	0.000845	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	9.1e-06	0.000824	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	7.78e-06	0.000705	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—TYMP—urinary bladder cancer	7.28e-06	0.000659	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—TYMS—urinary bladder cancer	7.24e-06	0.000655	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	7.15e-06	0.000648	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	7.15e-06	0.000648	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—GPX1—urinary bladder cancer	6.85e-06	0.00062	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	6.72e-06	0.000609	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—NAT2—urinary bladder cancer	6.58e-06	0.000596	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	6.32e-06	0.000572	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—RRM2—urinary bladder cancer	5.68e-06	0.000514	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—ENO2—urinary bladder cancer	5.26e-06	0.000476	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	5.26e-06	0.000476	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—PPARG—urinary bladder cancer	5.13e-06	0.000464	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	5.1e-06	0.000462	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	4.92e-06	0.000446	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—NQO1—urinary bladder cancer	4.24e-06	0.000384	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	4.03e-06	0.000365	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	3.54e-06	0.00032	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—PTEN—urinary bladder cancer	3.52e-06	0.000318	CbGpPWpGaD
Permethrin—CYP2B6—Metabolism—EP300—urinary bladder cancer	3.35e-06	0.000304	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—TYMS—urinary bladder cancer	3.29e-06	0.000298	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	3.25e-06	0.000294	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	3.25e-06	0.000294	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—GPX1—urinary bladder cancer	3.11e-06	0.000282	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	3.06e-06	0.000277	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	2.87e-06	0.00026	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—PPARG—urinary bladder cancer	2.33e-06	0.000211	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	2.24e-06	0.000203	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.83e-06	0.000166	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.6e-06	0.000145	CbGpPWpGaD
Permethrin—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.52e-06	0.000138	CbGpPWpGaD
